Yahoo Web Search

  1. Patients with relapsing remitting multiple sclerosis (RRMS) who received Sanofi Genzyme’s Lemtrada [®] (alemtuzumab) experienced effects of treatment on disease activity that were ...

  2. New guidelines on the use of disease-modifying therapies (DMTs) in patients with multiple sclerosis (MS) provide updated guidance on starting, switching, and stopping treatment ...

  3. The company's top-earning multiple sclerosis drug Tecfidera brought in a revenue of $987 million in the quarter, falling short of analyst estimate of $1.02 billion. Sales of spinal ...

  4. BIRMINGHAM, Ala. – A rehabilitation technique originally developed for stroke has now been shown to also be effective for improving function for people with multiple sclerosis, ...

  5. Not only can cannabis work for a variety of conditions such as epilepsy, multiple sclerosis and pain, sometimes, it is the only thing that works. It is time for safe and regulated ...

  6. The safety data was consistent with the drug’s favorable benefit-risk profile in both relapsing and primary progressive multiple sclerosis.

  7. The annual event to raise awareness and funds to fight multiple sclerosis is set for this Saturday, April 28, at Tusculum College. Registration and sign-in will begin at 9 a.m.

  8. The company has been banking on Spinraza's success to prop up slowing growth of its multiple sclerosis drug Tecfidera, which is facing increasing competition. Spinraza, the first ...

  9. Jennie Wilson Elementary School hosting 5K run

    The Garden City Telegram5 hours ago

    Jennie Wilson Elementary School will host a four-school, 5K and one mile fun run on Saturday to promote the awareness of multiple sclerosis and muscular dystrophy. The race will ...

  10. BIIB holds a strong position in the multiple sclerosis (MS) market with a wide range of products including Avonex, Tysabri, Tecfidera and Plegridy. However, as competition in the ...

  1. 12345349 results